All filters
Slidesets
HIV integrase Inhibitors: A novel mechanisms of action- Dr. H. Wu
Presented at:
Chinese HIV Clinical Forum 2018
Slidesets
Resistance Characteristics of different Integrase Inhibitors- Charles Boucher, MD, PhD
Presented at:
Chinese HIV Clinical Forum 2018
Slidesets
Abstract-driven presentation: Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Treatment-Naïve Asian Adults: Week 144 results- Tina Zheng
Presented at:
Chinese HIV Clinical Forum 2018
Slidesets
Resistance Characteristics of different Integrase Inhibitors- Charles Boucher, MD, PhD
Presented at:
Chinese HIV Clinical Forum 2018
Slidesets
Optimal use of integrase inhibitors in routine clinical practice- Kees Brinkman, MD, PhD
Presented at:
Chinese HIV Clinical Forum 2018
Slidesets
Optimal use of integrase inhibitors in routine clinical practice- Kees Brinkman, MD, PhD
Presented at:
Chinese HIV Clinical Forum 2018
Slidesets
Abstract-driven presentation: Efficacy and Safety of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir alafenamide (E/C/F/TAF) in Virologically Suppressed Asian Adults with Renal Impairment: 144 Week- Ning Li
Presented at:
Chinese HIV Clinical Forum 2018
Slidesets
Taiwan’s Experiences with Integrase Inhibitors- Chien-Ching Hung, MD, PhD
Presented at:
Chinese HIV Clinical Forum 2018
Slidesets
Long-term HIV treatment: The Importance of Initial Antiretroviral Regimen Selection- Hongxin Zhao, MD, MPH
Presented at:
Chinese HIV Clinical Forum 2018